Low utilization of epidemiological cutoff values to interpret <i>in vitro</i> antifungal susceptibility testing among clinical laboratory participants in two College of American Pathologists (CAP) proficiency testing programs-Reference-Cited by-同舟云学术

Low utilization of epidemiological cutoff values to interpret in vitro antifungal susceptibility testing among clinical laboratory participants in two College of American Pathologists (CAP) proficiency testing programs

Published:2024-07-16 Issue:7 Volume:62 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Sullivan Kaede V.¹^ORCID,Long Thomas²,Hillesland Erica³,Rhoads Daniel D.⁴^ORCID,Wojewoda Christina M.⁵^ORCID,Zhang Sean X.⁶^ORCID

Affiliation:

1. Department of Pathology & Laboratory Medicine, Temple University Health System, Philadelphia, Pennsylvania, USA

2. Department of Biostatistics, College of American Pathologists, Chicago, Illinois, USA

3. Laboratory Improvement Programs Proficiency Testing Department, College of American Pathologists, Chicago, Illinois, USA

4. Department of Pathology & Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA

5. Department of Pathology & Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont, USA

6. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Publisher

American Society for Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/jcm.00421-24

Reference7 articles.

1. What Is New in Fungal Infections?

2. Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap

3. Clinical and Laboratory Standards Institute. 2022. Performance standards for antifungal susceptibility testing of yeasts. In CLSI supplement M27M44S, 3rd ed. Clinical and Laboratory Standards Institute, USA, Wayne, PA.

4. European Committee on Antimicrobial Susceptibility Testing. 2020 EUCAST clinical breakpoints for fungi (Candida and Aspergillus species). Available from: https://www.eucast.org/astoffungi/clinicalbreakpointsforantifungals

5. Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard